Cardioline Acquires Cardios, Bolstering Cardiac Diagnostics

Cardioline Holding spa, a prominent player in advanced cardiac diagnostics technology and backed by European private equity firm Archimed, has significantly bolstered its international presence with the acquisition of Brazilian firm Cardios. This strategic move, facilitated by financing from Solution Bank, marks a key expansion into the Latin American market for the Italian-based holding company.

Cardios, headquartered in São Paulo, is a well-established entity specializing in non-invasive cardiac diagnostic tools and telecardiology solutions. Founded in 1977, the company holds a pioneering reputation in Brazil, particularly for its early adoption and development of Holter monitoring systems. The acquisition positions Cardioline to leverage Cardios' deep market penetration and decades of operational expertise within Brazil's healthcare sector.

The seller, Halma plc, a global FTSE 100-listed technology group, divested Cardios as part of its strategic portfolio adjustments. Halma had originally acquired Cardios in 2016 with the objective of broadening its footprint in South America's health technology segment. This transaction underscores the dynamic nature of the medical device industry, where strategic acquisitions and divestitures are common as companies refine their focus.

While specific financial terms of the deal were not disclosed, industry estimates place Cardios' annual revenue in the range of $12 million to $15 million. This acquisition aligns with the broader trend of consolidation within the global cardiac monitoring and diagnostics market, a sector projected for steady growth driven by an aging population and increasing prevalence of cardiovascular diseases. The market for remote patient monitoring, in particular, is experiencing robust expansion, fueled by technological advancements and a growing demand for accessible healthcare solutions.

Cardioline Holding, under Archimed's ownership since 2021, is dedicated to developing and manufacturing cutting-edge cardiac diagnostic technologies. The integration of Cardios is expected to create significant synergies, enhancing Cardioline's product portfolio and expanding its geographical reach. The transaction was supported by the FEI – InvestEU guarantee, highlighting the collaborative efforts between private equity, financial institutions, and European funding initiatives to support cross-border M&A activities.

Legal and financial advisory services played a crucial role in navigating the complexities of this cross-border transaction. Solution Bank was advised by Lawal Legal & Tax Advisory. Cardioline Holding received corporate and financing legal counsel from Herbert Smith Freehills Kramer, alongside Brazilian legal expertise from Vella Pugliese Buosi Guidoni Advogados and Guarnera Advogados. This intricate network of advisors ensured a smooth execution of the acquisition and its associated financing.